1.
Ann Allergy
; 39(2): 102-5, 1977 Aug.
Article
in English
| MEDLINE
| ID: mdl-407817
ABSTRACT
In a preliminary double-blind, placebo controlled, crossover study, 10 out of 16 patients (62.5%) had remissions in acute symptoms of food allergy with oral cromolyn therapy. The effective dosage for each patient had to be sought individually. No serious side effects were encountered.
Subject(s)
Cromolyn Sodium/therapeutic use , Food Hypersensitivity/drug therapy , Administration, Oral , Adolescent , Adult , Aged , Allergens/administration & dosage , Child, Preschool , Clinical Trials as Topic , Colic/drug therapy , Cromolyn Sodium/administration & dosage , Female , Humans , Infant , Male , Middle Aged , Remission, Spontaneous
2.
Ann Allergy
; 38(1): 42-45, 1977 Jan.
Article
in English
| MEDLINE
| ID: mdl-402093
ABSTRACT
In a double-blind, crossover, placebo-controlled study, consisting of 100 clinical trials, the active drug (sodium cromoglycate) was effective in 83.2%, while in 11.6% the placebo was judged more effective (p less than 0.0001). Four patients suffered minor side effects. No deleterious effect on the nasal mucosa was noticed and no one complained that the drug produced sedation.
Subject(s)
Cromolyn Sodium/therapeutic use , Rhinitis, Allergic, Seasonal/drug therapy , Adolescent , Adult , Child , Clinical Trials as Topic , Eosinophils , Female , Humans , Male , Middle Aged , Nasal Mucosa/cytology , Nasal Mucosa/drug effects , Rhinitis, Allergic, Seasonal/blood
3.
Ann Allergy
; 33(2): 78-85, 1974 Aug.
Article
in English
| MEDLINE
| ID: mdl-4843629
